ARTICLE | Company News
Matritech other research news
October 2, 1995 7:00 AM UTC
The Cambridge, Mass., company received a $93,000 Phase I SBIR from the National Cancer Institute to develop an assay to screen for cancer compounds using NuMA. NMPS said that NuMA is over-expressed in...